- Author
- Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)
- Organization
- Keywords
- mRNA vaccine, Lipid nanoparticle, Cancer immunotherapy, Type I IFN, Checkpoint inhibition, T-CELL RESPONSES, LIPID NANOPARTICLE FORMULATIONS, PERIPHERAL LYMPHOID ORGANS, ANTIGEN-PRESENTING CELLS, DENDRITIC CELLS, IN-VIVO, IMMUNE-RESPONSES, CANCER-IMMUNOTHERAPY, DIRECT-INJECTION, CAP-ANALOGS
Downloads
-
Verbeke. et al. Three decades of mRNA vaccine development.pdf
- full text
- |
- open access
- |
- |
- 1.86 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8628303
- MLA
- Verbeke, Rein, et al. “Three Decades of Messenger RNA Vaccine Development.” NANO TODAY, vol. 28, 2019, doi:10.1016/j.nantod.2019.100766.
- APA
- Verbeke, R., Lentacker, I., De Smedt, S., & Dewitte, H. (2019). Three decades of messenger RNA vaccine development. NANO TODAY, 28. https://doi.org/10.1016/j.nantod.2019.100766
- Chicago author-date
- Verbeke, Rein, Ine Lentacker, Stefaan De Smedt, and Heleen Dewitte. 2019. “Three Decades of Messenger RNA Vaccine Development.” NANO TODAY 28. https://doi.org/10.1016/j.nantod.2019.100766.
- Chicago author-date (all authors)
- Verbeke, Rein, Ine Lentacker, Stefaan De Smedt, and Heleen Dewitte. 2019. “Three Decades of Messenger RNA Vaccine Development.” NANO TODAY 28. doi:10.1016/j.nantod.2019.100766.
- Vancouver
- 1.Verbeke R, Lentacker I, De Smedt S, Dewitte H. Three decades of messenger RNA vaccine development. NANO TODAY. 2019;28.
- IEEE
- [1]R. Verbeke, I. Lentacker, S. De Smedt, and H. Dewitte, “Three decades of messenger RNA vaccine development,” NANO TODAY, vol. 28, 2019.
@article{8628303, articleno = {{100766}}, author = {{Verbeke, Rein and Lentacker, Ine and De Smedt, Stefaan and Dewitte, Heleen}}, issn = {{1748-0132}}, journal = {{NANO TODAY}}, keywords = {{mRNA vaccine,Lipid nanoparticle,Cancer immunotherapy,Type I IFN,Checkpoint inhibition,T-CELL RESPONSES,LIPID NANOPARTICLE FORMULATIONS,PERIPHERAL LYMPHOID ORGANS,ANTIGEN-PRESENTING CELLS,DENDRITIC CELLS,IN-VIVO,IMMUNE-RESPONSES,CANCER-IMMUNOTHERAPY,DIRECT-INJECTION,CAP-ANALOGS}}, language = {{eng}}, pages = {{17}}, title = {{Three decades of messenger RNA vaccine development}}, url = {{http://doi.org/10.1016/j.nantod.2019.100766}}, volume = {{28}}, year = {{2019}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: